Delivery Order SPE2DB22D2007-SPE2DB26FH6PD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,777.72 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. This contract, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. The award was made competitively and represents a specific fulfillment requirement under AmerisourceBergen's larger federal contract vehicle supporting military healthcare procurement....
- The Defense Logistics Agency (DLA) awarded a $10,518.48 delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,308.18 for 400 mg Benlysta vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the major pharmaceutical distributor for medical supplies supporting federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,518.48 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single procurement action under the company's broader pharmaceutical supply agreement with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $6,152.80 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Benlysta 200 mg/ml syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, valued at $12,330.68 for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside delivery order with a completion deadline of September 8, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $4,987.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector pharmaceutical supplies. The contract, effective May 27, 2025, with completion targeted for June 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $9,248.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector units. The contract, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of November 10, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6PDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,740.12 to AmerisourceBergen Drug Corp for the supply of Benlysta 120 mg vials, with an ultimate completion date of November 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the place of performance for this transaction. This delivery order is part of AmerisourceBergen's comprehensive federal pharmaceutical supply portfolio, which includes support for military and veteran healthcare systems through DLA's medical supply chain. As a major pharmaceutical distributor, AmerisourceBergen holds a prime IDC valued at $999,999,999.00 that extends through December 2026, enabling the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. The Benlysta vials delivered under this order support pharmaceutical needs across the federal military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 10/29/25 |